TGM2 and cranioectodermal dysplasia: Available serological tests for CeD screening include anti‐tissue transglutaminase, anti‐endomysial, and anti‐deamidated gliadin peptide antibodies, with immunoglobulin A tissue transglutaminase generally considered to be the most sensitive and efficient test for CeD diagnosis.